Kenpaullone is primarily utilized in research settings as a potent inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase-3 (GSK-3). Its ability to modulate these kinases makes it a valuable tool in studying cell cycle regulation, neuronal development, and apoptosis. In neuroscience, it has been explored for its potential to promote neuronal survival and differentiation, offering insights into treatments for neurodegenerative diseases. Additionally, Kenpaullone has been investigated in cancer research due to its capacity to induce cell cycle arrest and apoptosis in various cancer cell lines. Its role in stem cell research is also notable, as it has been shown to enhance reprogramming efficiency in induced pluripotent stem cells (iPSCs). Overall, Kenpaullone serves as a versatile compound in biomedical research, contributing to advancements in understanding cellular mechanisms and developing therapeutic strategies.